120 related articles for article (PubMed ID: 35383609)
21. High-Risk human papillomavirus genotype distribution in the Northern region of Portugal: Data from regional cervical cancer screening program.
Sousa H; Tavares A; Campos C; Marinho-Dias J; Brito M; Medeiros R; Baldaque I; Lobo C; Leça L; Monteiro P; Tavares F; Henrique R
Papillomavirus Res; 2019 Dec; 8():100179. PubMed ID: 31377173
[TBL] [Abstract][Full Text] [Related]
22. [Time-Trends in Cervical Cancer Mortality in Portugal].
Teixeira C; Pereira AM; Anes E; Rodrigues C; Castanheira MJ
Acta Med Port; 2019 Jun; 32(6):427-433. PubMed ID: 31292023
[TBL] [Abstract][Full Text] [Related]
23. Cost-effectiveness of a stepwise intervention to promote adherence to cervical cancer screening.
Firmino-Machado J; Soeteman DI; Lunet N
Eur J Public Health; 2020 Jun; 30(3):401-410. PubMed ID: 31848592
[TBL] [Abstract][Full Text] [Related]
24. Factors associated with and socioeconomic inequalities in breast and cervical cancer screening among women aged 15-64 years in Botswana.
Keetile M; Ndlovu K; Letamo G; Disang M; Yaya S; Navaneetham K
PLoS One; 2021; 16(8):e0255581. PubMed ID: 34347841
[TBL] [Abstract][Full Text] [Related]
25. Impact of invitation and reminder letters on cervical cancer screening participation rates in an organized screening program.
Tavasoli SM; Pefoyo AJ; Hader J; Lee A; Kupets R
Prev Med; 2016 Jul; 88():230-6. PubMed ID: 27143497
[TBL] [Abstract][Full Text] [Related]
26. Trends in cervical cancer screening from 2007 to 2016: association with decreased genital melanoma detection in females.
Farr MA; Joshi TP; Lewis DJ
Int J Dermatol; 2022 Sep; 61(9):e326-e327. PubMed ID: 34403502
[No Abstract] [Full Text] [Related]
27. [Study on the coverage of cervical and breast cancer screening among women aged 35-69 years and related impact of socioeconomic factors in China, 2013].
Bao HL; Wang LH; Wang LM; Fang LW; Zhang M; Zhao ZP; Cong S
Zhonghua Liu Xing Bing Xue Za Zhi; 2018 Feb; 39(2):208-212. PubMed ID: 29495207
[No Abstract] [Full Text] [Related]
28. The paradigm shift in cervical cancer screening in Germany.
Hillemanns P
Arch Gynecol Obstet; 2016 Jan; 293(1):3-4. PubMed ID: 26514679
[TBL] [Abstract][Full Text] [Related]
29. Understanding Cervical Cancer Screening Barriers among Migrant Women: A Qualitative Study with Healthcare and Community Workers in Portugal.
Marques P; Gama A; Santos M; Heleno B; Vermandere H; Dias S
Int J Environ Res Public Health; 2021 Jul; 18(14):. PubMed ID: 34299698
[TBL] [Abstract][Full Text] [Related]
30. [Screening and early diagnosis of cervical cancer in a context of HPV vaccination].
Bergeron C
Rev Prat; 2010 Feb; 60(2):214-5. PubMed ID: 20225561
[No Abstract] [Full Text] [Related]
31. The rationale for implementation of HPV testing in routine cervical screening in Romania.
Iancu LS; Ursu RG
Rev Med Chir Soc Med Nat Iasi; 2013; 117(2):293-6. PubMed ID: 24340506
[No Abstract] [Full Text] [Related]
32. Cervical cytology screening programs: similarities and differences between the United States and United Kingdom systems.
Wilbur DC
Cancer Cytopathol; 2012 Apr; 120(2):102-4. PubMed ID: 22367853
[No Abstract] [Full Text] [Related]
33. Eradication of cervical cancer in Latin America.
Bosch FX
Salud Publica Mex; 2016 Apr; 58(2):97-100. PubMed ID: 27557367
[No Abstract] [Full Text] [Related]
34. Never and under cervical cancer screening in Switzerland and Belgium: trends and inequalities.
Jolidon V; De Prez V; Willems B; Bracke P; Cullati S; Burton-Jeangros C
BMC Public Health; 2020 Oct; 20(1):1517. PubMed ID: 33028278
[TBL] [Abstract][Full Text] [Related]
35. Comparative effectiveness of two outreach strategies for cervical cancer screening.
Bowles EJ; Gao H; Brandzel S; Bradford SC; Buist DS
Prev Med; 2016 May; 86():19-27. PubMed ID: 26820221
[TBL] [Abstract][Full Text] [Related]
36. Cervical cancer screening in Santiago Atitlán, Guatemala.
Frey MK; Roselli N; Gertz E; Cuc JC; Boyd L; Shirazian T
Int J Gynaecol Obstet; 2016 Oct; 135(1):119. PubMed ID: 27451397
[No Abstract] [Full Text] [Related]
37. Swimming upstream: doing less in health care is hard: comment on "No Papanicolaou tests in women younger than 21 years or after hysterectomy for benign disease" and "Cervical cancer screening intervals, 2006 to 2009".
LeFevre ML
JAMA Intern Med; 2013 May; 173(10):856-8. PubMed ID: 23568453
[No Abstract] [Full Text] [Related]
38. Cervical cancer screening research in the PROSPR I consortium: Rationale, methods and baseline findings from a US cohort.
Kamineni A; Tiro JA; Beaber EF; Silverberg MJ; Wheeler CM; Chao CR; Chubak J; Skinner CS; Corley DA; Kim JJ; Balasubramanian BA; Paul Doria-Rose V;
Int J Cancer; 2019 Mar; 144(6):1460-1473. PubMed ID: 30353911
[TBL] [Abstract][Full Text] [Related]
39. Temporal trend in socioeconomic inequalities in the uptake of cancer screening programmes in France between 2005 and 2010: results from the Cancer Barometer surveys.
Kelly DM; Estaquio C; Léon C; Arwidson P; Nabi H
BMJ Open; 2017 Dec; 7(12):e016941. PubMed ID: 29247085
[TBL] [Abstract][Full Text] [Related]
40. Socio-economic and demographic determinants affecting participation in the Swedish cervical screening program: A population-based case-control study.
Broberg G; Wang J; Östberg AL; Adolfsson A; Nemes S; Sparén P; Strander B
PLoS One; 2018; 13(1):e0190171. PubMed ID: 29320536
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
